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Abstract
A convenient two-step synthesis of ethyl 4-hydroxy-2-methylquinoline-3-carboxylate derivatives has been developed starting from
commercially available 2-aminobenzoic acids. In step 1, the anthranilic acids are smoothly converted to isatoic anhydrides using
solid triphosgene in THF. In step 2, the anhydride electrophiles are reacted with the sodium enolate of ethyl acetoacetate, generated
from sodium hydroxide, in warm N,N-dimethylacetamide resulting in the formation of substituted quinolines. A degradation–build-
up strategy of the ethyl ester at the 3-position allowed for the construction of the α-hydroxyacetic acid residue required for the syn-
thesis of key arylquinolines involved in an HIV integrase project.
Introduction
In stark contrast to the prevalence of the quinoline heterocycle
in natural products [1], quinolines are only present in approxi-
mately 2% of FDA approved prescription pharmaceuticals [2].
Recently, 2,3,4-trisubstituted arylquinolines such as BI 224436
1 [3,4] and 2 [5,6] have been shown to exhibit inhibitory activi-
ty against HIV-1 integrase that is essential for viral replication
through integration of viral DNA into host cell chromatin
(Figure 1) [7-9]. In contrast to the FDA approved integrase
strand transfer inhibitors (INSTIs) dolutegravir, elvitegravir,
and raltegravir, arylquinolines 1 and 2 bind to a non-catalytic
site of integrase (NCINI) via allosteric binding inhibition.
Structure–activity relationship studies have indicated that the
2-methyl and 3-acetic acid residues are crucial to maintaining
the potency of this scaffold [10]. The Boehringer Ingelheim
chemical development route toward the synthesis of quinoline 1
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Scheme 1: Boehringer Ingelheim retrosynthesis of quinoline 1.
Figure 1: Investigational non-catalytic HIV-1 Integrase inhibitors.
is shown in Scheme 1 [11]. The northern tricyclic heterocycle at
position 4 is installed by Suzuki coupling with iodide 3a that is
synthesized in three steps from ethyl aryl oxalate 4a. The
α-ketoester side chain at position 3 was installed by selective
halogen-metal exchange of iodide 5a with isopropylmagnesium
chloride lithium chloride complex followed by quenching with
ethyl chlorooxolate furnishing ethyl oxalate 4a in 29–79% yield
[12]. This sequence works well with the unsubstituted benzene
ring of the series a compounds where R = H. However, to
access quinoline 2 with scaffolds such as 4b with halogen sub-
stitution in the benzene ring at the 5-, 6-, 7- or 8-positions
would require a different strategy due to regioselectivity issues
encountered in the Grignard acylation step (5b→4b).
As part of an ongoing research program investigating new
assays toward integrase inhibition, we desired to synthesize
quinoline derivatives such as 2 with substitution in the benzene
ring of the quinolone [13]. The known synthesis of quinoline
core 8 has been published in a one-pot, two-step reaction from
4-bromoaniline (7) and diethyl acetylsuccinate in 36% yield
(Scheme 2) [14,15]. However, our attempts to repeat and scale-
up this procedure beyond a few hundred milligrams were met
with inconsistent results and variable yields. In our experience,
this route is less advantageous due to: (1) the need for a
prolonged room temperature condensation reaction time
(>5 days in a desiccator with phosphorus pentoxide) to form the
initial vinylogous amide; (2) the use of expensive diphenyl
ether, which has a nauseating odor, at 0.01 molar dilution at
reflux (259 °C) to effect the ring closure via electrophilic aro-
matic substitution; and (3) the aqueous work-up of this method
which does not reliably produce a precipitate that can be filtered
easily.
Scheme 2: Quinoline ring condensation strategies.
Given the regioselectivity issues and practical challenges asso-
ciated with the aniline cyclocondensation (7→8), along with the
scarcity of commercially available highly substituted quino-
lines, we sought to employ an entirely different tactic by
utilizing 2H-3,1-benzoxazine-2,4(1H)-dione (isatoic anhydride)
chemistry [16,17]. Isatoic anhydrides 9 are readily prepared
from inexpensive, commercially available 2-aminobenzoic acid
derivatives (anthranilic acids) with a variety of carbonyl transfer
reagents such as phosgene, triphosgene, carbonyldiimidazole, or
diethyl carbonate. We therefore employed a modified Coppola
quinoline synthesis method through the one-pot acylation of
ethyl acetoacetate with isatoic anhydrides followed by dehydra-
tive intramolecular cyclization to access the desired quinoline
scaffold 10 [18]. We replaced sodium hydride as the base re-
quired to generate the enolate of ethyl acetoacetate with sodium
hydroxide [19,20]. The use of sodium hydride is of particular
concern upon reaction scale-up due to limited solubility in
organic solvents and the production of flammable hydrogen gas
[21,22]. Sodium hydroxide avoids the off-gassing of hydrogen
Beilstein J. Org. Chem. 2018, 14, 2529–2536.
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Scheme 3: Isatoic anhydrides from anthranilic acids with triphosgene.
and produces water instead, thereby avoiding the use of any
special safety precautions.
Results and Discussion
The anhydrides 9a–h were readily accessible by treatment of
anthranilic acids AA with one equivalent of triphosgene in
refluxing tetrahydrofuran at 0.36 molar concentration
(Scheme 3). This procedure is an alternative to the existing
published protocol that relies on the use of toxic phosgene gas
[23] as the acylating agent by replacing it with the non-volatile
and weighable solid triphosgene [24,25]. After stirring for
12 hours, the reaction mixtures were quenched by pouring into
approximately 30 volumes of water (1 volume = 10 mL of
water per 1 gram of substrate) with subsequent stirring at room
temperature for one hour. The isatoic anhydride products 9a–h
typically precipitate out of solution and are readily collected by
vacuum filtration. This reverse aqueous quench provides suffi-
ciently pure material without the need for extraction with
organic solvent or additional purification. The reactions typical-
ly produced high purity products with some colored impurities
that were removed by slurring the crude filter cake in methanol
followed by vacuum filtration. HPLC analysis of the filtrate
showed minuscule loss of product due to this trituration. The
reaction is tolerant to halide substitution at the 6-, 7-, and
Scheme 4: Substituted 2-methyl-4-hydroxyquinolines from isatoic
anhydrides and ethyl acetoacetate.
8-positions (9b, 9c, 9f, 9h). The unprotected hydroxy group in
9d gave reasonably high yield as did electron-withdrawing nitro
groups in the 6- and 7-positions (9e, 9g).
The substituted isatoic anhydrides from Scheme 3 were then
subjected to the modified Coppola conditions for the synthesis
of 2-methylquinoline derivatives 10a–h (Scheme 4). Most sig-
nificantly, the investigation found that one equivalent of solid
sodium hydroxide in 0.6 molar N,N-dimethylacetamide at
100 °C was able to achieve the same result as the Coppola
protocol (NaH, DMA, 120 °C). While the use of sodium
hydroxide results in the production of water in the reaction me-
dium, we observed no evidence of hydrolysis of the ethyl esters
even at elevated temperatures. The reaction is operationally
robust and can be carried out without rigorous exclusion of
moisture or degassing protocols. As with the isatoic anhydride
step, the crude reaction mixtures were poured directly into
approximately 30 volumes of water and produced solid materi-
al that was readily collected via vacuum filtration. It should be
noted that addition of water directly to the reaction vessel did
Beilstein J. Org. Chem. 2018, 14, 2529–2536.
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Scheme 6: Quinoline synthesis with ethyl acetylpyruvate.
Scheme 5: Mechanistic hypothesis for the cyclocondensation reaction.
not have the same outcome, typically resulting in oiling out of
the product, and requiring organic solvent extraction. The yields
ranged from modest (47%) to excellent (97%) on scales from
1 gram up to 25 gram batches with spectral data matching
known quinolones [26].
A plausible mechanism for the formation of the quinoline is
shown in Scheme 5 [27]. After initial formation of the enolate
of ethyl acetoacetate with sodium hydroxide, water is generated
in the reaction mixture, which then serves as a proton transfer
agent. The resulting sodium enolate regioselectively attacks the
more electrophilic ester carbonyl of the isatoic anhydride
forming tetrahedral intermediate A. Subsequent collapse of the
sp3-hybridized carbon to the ketone B with concomitant
expulsion of carbon dioxide and enolization affords the
ketone C. The anion of the aniline nitrogen then attacks the
ketone carbonyl via intramolecular 6-exo-trig cyclization
and subsequent proton transfer to the aminal oxygen D. Elimi-
nation of the 2-hydroxy group from D then affords the
4-quinolone E that tautomerizes via [1,5]-hydride shift to form
quinoline 10.
Given the success of employing ethyl acetoacetate in the quino-
line cyclocondensation reaction (Scheme 4, 9→10), we hypoth-
esized that ethyl acetopyruvate could install the desired ethyl
2-oxoacetate residue at the 3-position as in 11 that is required
for the synthesis of quinolines 1 and 2 (Scheme 6). Whereas
with ethyl acetoacetate as shown in Scheme 5 can only
condense to form quinolines of type 10 via C→D, the ethyl
acetopyruvate has two carbonyls a and b as depicted in 13 that
result in regioisomeric products upon ring closure. The desired
quinoline 11 requires ring closure onto carbonyl b.
To that end, ethyl sodioacetopyruvate was prepared via Claisen
condensation of acetone with diethyl oxalate and sodium
ethoxide in ethanol [28]. Isatoic anhydride 9f was then added to
the solid enolate and both were dissolved in DMA and warmed
to 60 °C for 12 hours. Following the general work-up protocol
as described for Scheme 4, a light tan solid was isolated in
modest yield after trituration with methanol that was deter-
mined to be exclusively compound 12 by NMR. The formation
of either regioisomer 11 (via b) or 12 (via a) results from 6-exo-
trig cyclization of the common nucleophilic acyl substitution
intermediate 13. The 13C NMR data of the product has a singlet
at δ 199 ppm that shows a correlation by HMBC to the singlet
integrating to three protons in the 1H NMR at δ 2.52 ppm. That
same proton singlet in the HMBC only shows one other correla-
tion to a carbon singlet at δ 121.6 ppm. These methyl group
correlations can only be observed in compound 12 as the
HMBC experiment detects two and three-bond correlations. In
Beilstein J. Org. Chem. 2018, 14, 2529–2536.
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Scheme 8: Umpolung addition of ethoxycarbonyl via a MAC strategy.
Scheme 7: Elaboration of the benzoic acid ethyl ester to the acetic
acid residue.
11, correlation of the methyl singlet to the ketone is 4JCH and
would not be detected. The α-keto carbonyl group a in com-
pound 11 would be expected to have a chemical shift more
upfield than δ 199.3 ppm. Therefore, the product was deter-
mined to unequivocally be the undesired quinoline 12.
We then turned to a functional group transformation of the ethyl
ester at the 3-position to address the acetic acid sidechain prob-
lem (Scheme 7). First, the 4-hydroxy group in quinoline 10f
was substituted for chlorine with neat phosphorus oxychloride
to afford chloride 14 in 91% yield. The ethyl ester was then
smoothly reduced with DIBAL to the benzyl alcohol. While the
in-process analysis (TLC and HPLC) indicated quantitative
reduction, the isolated yields from the reductions were only
poor to modest despite utilizing standard workup conditions
with sodium potassium tartrate. Subsequent oxidation of the pri-
mary alcohol to the aldehyde 15 was accomplished with the
pyridine sulfur trioxide complex in 52% yield over two-steps
[29].
The carbon atom at the acid oxidation state was installed by ad-
dition of trimethylsilyl cyanide to the aldehyde 15 in the pres-
ence of lithium chloride in THF [30]. Initially, the trimethyl-
silyl cyanohydrin 16 was subjected to solvolysis in ethanol with
aqueous sulfuric acid. Unfortunately, those conditions resulted
in displacement of the 4-chloro substituent with ethanol giving
the 4-ethyl ether 17 in 35% yield. To circumvent this undesired
substitution at the 4-position, the cyanohydrin 16 was hydro-
lyzed by a two-step process. First, hydrogen chloride in ethanol
(3.3 molar) was used to produce the imidate 18 in quantitative
yield. The structure of 18 was verified by NMR to prove that
the 4-position had not suffered displacement by ethanol. Subse-
quent hydrolysis of 18 with dilute aqueous hydrochloric acid
afforded the desired ethyl ester 19 in 59% yield. Given the three
steps required to convert the aldehyde 15 into the desired
α-hydroxy acetic acid ethyl ester 19, we decided to pursue a
more direct one-carbon homologation procedure.
We envisioned a milder alternative to the acidic conditions re-
quired for cyanide hydrolysis that would provide the side chain
at the correct oxidation in one pot. To that end, we turned to
masked acyl cyanide (MAC) chemistry [31] in which the
reagent 20 acts as an acyl anion via umpolung reactivity [32].
With the aldehyde 15 in hand, homologation involving the addi-
tion of the MAC reagent 20 afforded the TBS protected
α-hydroxyacetic acid ethyl ester 21 in in 76% yield (Scheme 8).
Based on the purported mechanistic reasoning of Nemoto, addi-
tion of the methine anion of 20 to 15 proceeds to the intermedi-
ate alkoxide G that undergoes a [1,4]-shift of the silicon group
with concomitant ejection of cyanide anion to form acyl
cyanide H [33]. As the reaction is run in the presence of
Beilstein J. Org. Chem. 2018, 14, 2529–2536.
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ethanol, nucleophilic acyl substitution of cyanide H for the
ethoxy group furnishes the ethyl ester 21 in one pot. We were
therefore able to construct the desired benzene substituted
quinoline 21 in six steps from 2-amino-4-bromobenzoic acid in
31% overall yield.
Conclusion
In conclusion, an efficient route for the synthesis of substituted
quinolines 10a–h has been demonstrated from commercially
available anthranilic acids AA (Scheme 4). This strategy
achieved the replacement of sodium hydride with sodium
hydroxide thereby obviating any special equipment requiring
the capture or scrubbing of hydrogen gas evolved. The exten-
sion of the 3-position ethyl ester into the α-tert-butoxy acetic
acid residue was also demonstrated via a cyanohydrin-hydroly-
sis route (10f→19) and an umpolung acyl addition strategy
(10f→21). The development of a library of quinoline scaffolds
is currently underway within our lab utilizing this synthetic
process [34,35].
Experimental
General procedure for isatoic anhydride
synthesis
6-Bromo-2H-benzo[d][1,3]oxazine-2,4(1H)-dione (9b). A
500 mL single neck round-bottomed flask equipped with a foot-
ball-shaped PTFE stirring bar (16 mm × 37 mm) was charged
with 2-amino-5-bromobenzoic acid (10.0 g, 46.3 mmol,
1.0 equiv) followed by the addition of tetrahydrofuran (230 mL,
0.2 molar) and solid triphosgene (13.7 g, 46.3 mmol, 1.0 equiv)
resulting in a suspension. The reaction vessel was placed into a
fitted metal heating mantle and the neck was equipped with a
24/40 Liebig condenser. The suspension was stirred (500 rpm)
and the heating mantle set to 70 °C. The suspension became
homogenous before a white solid precipitated out after about
30 minutes at 70 °C. The heterogeneous reaction mixture was
aged for 12 hours then cooled to room temperature (25 °C). The
slurry was poured into a 600 mL beaker equipped with over-
head mechanical stirrer (PTFE 75 mm paddle) containing
250 mL of deionized water. With vigorous stirring, the mixture
became homogenous followed by precipitation of a pale white
solid. The solid was collected by vacuum filtration on a
Büchner funnel (7.6 cm diameter) with Whatman #1 filter paper
(70 mm) and air pulled through for 5 minutes. The material was
transferred to a 250 mL Erlenmeyer flask equipped with cylin-
drical stir bar and 50 mL of methanol was added. The slurry
was stirred for 10 minutes and then collected by vacuum filtra-
tion. The filter cake was dried under vacuum (0.1 mmHg at
25 °C) for 12 hours to afford 9b as a white powder (90% yield).
Physical characteristics of 9b: white powder with 95.4% purity
as determined by quantitative 1H NMR using maleic acid as the
internal standard; mp > 270 °C; IR (solid) cm−1: 3170, 1751;
1H NMR (DMSO-d6, 400 MHz) δ 11.86 (s, 1H, N-H), 7.98 (d,
J = 2.3 Hz, 1H, Ce-H), 7.88 (dd, J = 8.7, 2.3 Hz, 1H, Cd-H),
7.19 (d, J = 8.7 Hz, 1H, Cf-H); 13C NMR (DMSO-d6,
100 MHz) δ 158.8 (s, Ca), 146.7 (s, Cb), 140.6 (s, Cc), 139.3
(d, Cd), 130.5 (d, Ce), 117.6 (d, Cf), 114.5 (s, Cg), 112.4 (s,
Ch); HRMS (ESI): calcd for [C8H4BrNO3 + Na]+ 263.926677;
found: 263.926475; anal. calcd for C8H4BrNO3: C, 50.34; H,
3.90; found: C, 49.98; H, 3.80.
General procedure for quinoline synthesis
Ethyl 6-bromo-4-hydroxy-2-methyl-3-carboxylate (10b). To
a 250 mL single-necked round bottom flask equipped with foot-
ball-shaped PTFE stir bar (16 mm × 37 mm) was added isatoic
anhydride 9b (10.85 g, 44.8 mmol, 1.0 equiv), ethyl aceto-
acetate (11.3 mL, 89.7 mmol, 2.0 equiv), and N,N-dimethylacet-
amide (75 mL, 0.6 molar) resulting in a clear yellow solution.
To the reaction solution was then added solid sodium hydrox-
ide (1.79 g, 44.8 mmol, 1.0 equiv) that dissolved over time. The
reaction vessel was placed in a fitted metal heating mantle and
heated at 100 °C for 12 hours. The reaction solution was cooled
to room temperature (25 °C) and poured into a 500 mL beaker
equipped with cylindrical PTFE stir bar (16 mm × 37 mm) con-
taining 250 mL of deionized water causing a beige solid to pre-
cipitate out of solution. The solid was collected on a Büchner
funnel (7.6 cm diameter) with Whatman #1 filter paper (70 mm)
and air dried by pulling a vacuum through for 10 minutes. The
material was further dried in a vacuum oven (0.1 mmHg at
25 °C) for 24 hours to afford 11.1g of 10b as a white powder
(80% yield). Physical and spectroscopic characteristics of 10b:
white powder with 97.9% purity as determined by quantitative
1H NMR using maleic acid as the internal standard;
mp 270–272 °C; IR (solid) cm−1 1705; 1H NMR (DMSO-d6,
400 MHz) δ 12.03 (s, 1H, O-H), 8.13 (d, J = 2.3 Hz, 1H, Cf-H),
7.82 (dd, J = 8.8, 2.4 Hz, 1H, Ce-H), 7.51 (d, J = 8.8 Hz, 1H,
Ch-H), 4.24 (q, J = 7.1 Hz, 2H, Ck-H), 2.39 (s, 3H, Cl-H), 1.27
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(t, J = 7.1 Hz, 1H, Cm-H); 13C NMR (DMSO-d6, 100 MHz)
δ 172.0 (s, Ca), 166.4 (s, Cb), 149.4 (s, Cc), 138.0 (s, Cd),
134.9 (d, Ce), 127.1 (d, Cf), 126.0 (s, Cg), 120.6 (d, Ch), 116.3
(s, Ci), 115.0 (s, Cj), 60.4 (t, Ck), 18.2 (q, Cl), 14.1 (q, Cm);
HRMS (ESI): calcd for [C13H12BrNO3 + Na]+ 331.989277;
found: 331.988788; anal. calcd for C13H12BrNO3: C, 39.70; H,
1.67; found C, 39.51; H, 1.74.
Supporting Information
Supporting Information File 1
Experimental procedures and analytical data.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-14-229-S1.pdf]
Supporting Information File 2
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